tiprankstipranks
Redcare Pharmacy (DE:RDC)
XETRA:RDC
Germany Market

Redcare Pharmacy (RDC) Stock Forecast & Price Target

68 Followers
See the Price Targets and Ratings of:

RDC Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
5 Buy
2 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Redcare
Pharmacy
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

RDC Stock 12 Month Forecast

Average Price Target

€97.93
▲(163.11% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Redcare Pharmacy in the last 3 months. The average price target is €97.93 with a high forecast of €150.00 and a low forecast of €40.00. The average price target represents a 163.11% change from the last price of €37.22.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"36":"€36","151":"€151","64.75":"€64.8","93.5":"€93.5","122.25":"€122.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":150,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€150.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97.92857142857142,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€97.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":40,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€40.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[36,64.75,93.5,122.25,151],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.14,45.821538461538466,54.503076923076925,63.184615384615384,71.86615384615385,80.54769230769232,89.22923076923078,97.91076923076923,106.5923076923077,115.27384615384616,123.95538461538463,132.6369230769231,141.31846153846155,{"y":150,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.14,41.816043956043956,46.49208791208791,51.168131868131866,55.84417582417582,60.520219780219776,65.19626373626373,69.87230769230769,74.54835164835164,79.2243956043956,83.90043956043955,88.5764835164835,93.25252747252746,{"y":97.92857142857142,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.14,37.36,37.58,37.8,38.02,38.24,38.46,38.68,38.9,39.12,39.34,39.56,39.78,{"y":40,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":122.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":131.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.9,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.25,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.75,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.05,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.7,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.35,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":59.4,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.14,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€150.00Average Price Target€97.93Lowest Price Target€40.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on DE:RDC
Kepler Capital
Kepler Capital
€100€40
Hold
7.47%
Upside
Downgraded
03/30/26
Redcare Pharmacy (0RJT) was downgraded to a Hold Rating at Kepler Capital
Deutsche Bank  Analyst forecast on DE:RDC
Deutsche Bank
Deutsche Bank
€99
Buy
165.99%
Upside
Reiterated
03/20/26
Deutsche Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
Berenberg Bank Analyst forecast on DE:RDC
Berenberg Bank
Berenberg Bank
€165€87.5
Buy
135.09%
Upside
Reiterated
03/06/26
Berenberg Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
Barclays
€110
Buy
195.54%
Upside
Reiterated
03/04/26
Barclays Sticks to Its Buy Rating for Redcare Pharmacy (0RJT)
UBS
€74
Hold
98.82%
Upside
Reiterated
03/04/26
UBS Reaffirms Their Hold Rating on Redcare Pharmacy (0RJT)
Jefferies
€150
Buy
303.01%
Upside
Reiterated
03/04/26
Buy Rating Maintained as Strong Prescription Growth and Long-Term Margin Ambition Outweigh Near-Term Profitability Pressure
Baader Bank Analyst forecast on DE:RDC
Baader Bank
Baader Bank
€125
Buy
235.84%
Upside
Reiterated
03/04/26
Baader Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
Cantor Fitzgerald Analyst forecast on DE:RDC
Cantor Fitzgerald
Cantor Fitzgerald
€175€170
Buy
356.74%
Upside
Reiterated
05/07/25
Hauck & Aufhaeuser Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Kepler Capital  Analyst forecast on DE:RDC
Kepler Capital
Kepler Capital
€100€40
Hold
7.47%
Upside
Downgraded
03/30/26
Redcare Pharmacy (0RJT) was downgraded to a Hold Rating at Kepler Capital
Deutsche Bank  Analyst forecast on DE:RDC
Deutsche Bank
Deutsche Bank
€99
Buy
165.99%
Upside
Reiterated
03/20/26
Deutsche Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
Berenberg Bank Analyst forecast on DE:RDC
Berenberg Bank
Berenberg Bank
€165€87.5
Buy
135.09%
Upside
Reiterated
03/06/26
Berenberg Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
Barclays
€110
Buy
195.54%
Upside
Reiterated
03/04/26
Barclays Sticks to Its Buy Rating for Redcare Pharmacy (0RJT)
UBS
€74
Hold
98.82%
Upside
Reiterated
03/04/26
UBS Reaffirms Their Hold Rating on Redcare Pharmacy (0RJT)
Jefferies
€150
Buy
303.01%
Upside
Reiterated
03/04/26
Buy Rating Maintained as Strong Prescription Growth and Long-Term Margin Ambition Outweigh Near-Term Profitability Pressure
Baader Bank Analyst forecast on DE:RDC
Baader Bank
Baader Bank
€125
Buy
235.84%
Upside
Reiterated
03/04/26
Baader Bank Reaffirms Their Buy Rating on Redcare Pharmacy (0RJT)
Cantor Fitzgerald Analyst forecast on DE:RDC
Cantor Fitzgerald
Cantor Fitzgerald
€175€170
Buy
356.74%
Upside
Reiterated
05/07/25
Hauck & Aufhaeuser Sticks to Their Buy Rating for Redcare Pharmacy (0RJT)
Stocks with the Highest Top Analyst Consensus in the General Sector
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Redcare Pharmacy

3 Months
xxx
Success Rate
23/32 ratings generated profit
72%
Average Return
+20.44%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.88% of your transactions generating a profit, with an average return of +20.44% per trade.
1 Year
Christian SalisCantor Fitzgerald
Success Rate
21/32 ratings generated profit
66%
Average Return
+54.49%
Copying Christian Salis's trades and holding each position for 1 Year would result in 65.63% of your transactions generating a profit, with an average return of +54.49% per trade.
2 Years
xxx
Success Rate
16/32 ratings generated profit
50%
Average Return
+50.82%
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +50.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RDC Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
15
11
11
17
9
Buy
0
2
2
2
0
Hold
1
2
2
3
2
Sell
2
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
15
15
22
11
In the current month, RDC has received 9 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. RDC average Analyst price target in the past 3 months is 97.93.
Each month's total comprises the sum of three months' worth of ratings.

RDC Financial Forecast

RDC Earnings Forecast

The previous quarter’s earnings for RDC were -€1.44.
The previous quarter’s earnings for RDC were -€1.44.

RDC Sales Forecast

Next quarter’s sales forecast for RDC is €824.00M with a range of €815.00M to €833.00M. The previous quarter’s sales results were €795.19M. RDC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year RDC has Performed in-line its overall industry.
Next quarter’s sales forecast for RDC is €824.00M with a range of €815.00M to €833.00M. The previous quarter’s sales results were €795.19M. RDC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year RDC has Performed in-line its overall industry.

RDC Stock Forecast FAQ

What is DE:RDC’s average 12-month price target, according to analysts?
Based on analyst ratings, Redcare Pharmacy’s 12-month average price target is 97.93.
    What is DE:RDC’s upside potential, based on the analysts’ average price target?
    Redcare Pharmacy has 163.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Redcare Pharmacy a Buy, Sell or Hold?
          Redcare Pharmacy has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Redcare Pharmacy’s share price target?
            The average share price target for Redcare Pharmacy is 97.93. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €150.00 ,and the lowest forecast is €40.00. The average share price target represents 163.11% Increase from the current price of €37.22.
              What do analysts say about Redcare Pharmacy?
              Redcare Pharmacy’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of Redcare Pharmacy?
                To buy shares of DE:RDC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.